• Home
  • About
  • Partnerships
  • iProgen Technology
  • Careers
  • News
  • Contact
  • Home
  • About
  • Partnerships
  • iProgen Technology
  • Careers
  • News
  • Contact
  • Home
  • About
  • Partnerships
  • iProgen Technology
  • Careers
  • News
  • Contact
  • Home
  • About
  • Partnerships
  • iProgen Technology
  • Careers
  • News
  • Contact
  • Home
  • About
  • Partnerships
  • iProgen Technology
  • Careers
  • News
  • Contact
  • Home
  • About
  • Partnerships
  • iProgen Technology
  • Careers
  • News
  • Contact
  • News Spotlight
    April 13, 2022 August 27, 2026Pioneering research collaboration to treat Sarcopenia using Antibody Drug Conjugate technology
    Asan Medical Center (AMC) and iProgen Biotech Inc., enters research collaboration to explore the application of Antibody Drug...
    By tech@playheads.ca 263 Likes
Search posts
About Me
Author Image
Colene Landin
Co-founder

Lorem ipsum is simply dummy text of the printing and industry lorem ipsum has been standard.

Categories
  • News Spotlight 09
Recent posts
  • iProgen Out-Licenses AntibodyInternalization Technologies to AOCeraTherapeutics for Antibody Oligo ConjugateApplication.
    May 29, 2026iProgen Biotech out-licensed its Antibody...
  • iProgen and UBC Out-License NovelDegrader Antibody ConjugateTechnology to 3C Therapeutics Inc.
    iProgen Biotech and the University of British...
  • iProgen has out-licensed its protein internalization technology to Lucy Biotech Ltd. for the delivery of Anti-Freeze Proteins
    iProgen Biotech out-licensed its intracellular protein delivery...
Instagram
  • Please enter valid Access Token.

Company

  • Home
  • About Us
  • Partnerships
  • Careers
  • Latest News

Weekly Newsletter

Stay informed, stay ahead! Subscribe to our newsletter now for regular updates, insightful articles, and exclusive insights delivered right to your inbox.

Linkedin

iProgen Holds All Exclusive Rights.

Designed & Developed by  PLAYHEADS